dextrothyroxine has been researched along with Invasiveness, Neoplasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, S; Yi, J; Zhai, W; Zhang, G; Zhang, X; Zhao, Z | 1 |
| Bi, S; Chen, L; Wang, C; Wei, Q; Xie, S; Zhao, Z | 1 |
2 other study(ies) available for dextrothyroxine and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Inhibition of TMEM16A Ca
Topics: Adenocarcinoma of Lung; Animals; Anoctamin-1; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; CHO Cells; Cricetulus; Ivermectin; Lung Neoplasms; Male; Membrane Potentials; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Signal Transduction; Tumor Burden | 2020 |
Ivermectin suppresses tumour growth and metastasis through degradation of PAK1 in oesophageal squamous cell carcinoma.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cisplatin; Down-Regulation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Ivermectin; Male; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Neoplasm Invasiveness; Neoplasm Metastasis; p21-Activated Kinases; Proteolysis; Signal Transduction; Ubiquitin | 2020 |